55 related articles for article (PubMed ID: 2163022)
1. Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system.
Tota MR; Schimerlik MI
Mol Pharmacol; 1990 Jun; 37(6):996-1004. PubMed ID: 2163022
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of the purified porcine atrial muscarinic acetylcholine receptor with purified porcine atrial inhibitory guanine nucleotide binding protein.
Tota MR; Kahler KR; Schimerlik MI
Biochemistry; 1987 Dec; 26(25):8175-82. PubMed ID: 3126798
[TBL] [Abstract][Full Text] [Related]
3. M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?
Van Gelderen JG; Daeffler L; Scherrer D; Mousli M; Landry Y; Gies JP
J Recept Signal Transduct Res; 1996; 16(1-2):135-48. PubMed ID: 8771535
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of muscarinic receptor-mediated inhibition of adenylyl cyclase.
Tota MR; Xia ZQ; Storm DR; Schimerlik MI
Mol Pharmacol; 1990 Jun; 37(6):950-7. PubMed ID: 2113606
[TBL] [Abstract][Full Text] [Related]
5. Regulation of guanine nucleotide turnover on Gi/Go by agonist-stimulated and spontaneously active muscarinic receptors in cardiac membranes.
Quist E; Satumtira N; Vasan R
Arch Biochem Biophys; 1999 Jan; 361(1):57-64. PubMed ID: 9882428
[TBL] [Abstract][Full Text] [Related]
6. Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
Matesic DF; Manning DR; Luthin GR
Mol Pharmacol; 1991 Sep; 40(3):347-53. PubMed ID: 1716729
[TBL] [Abstract][Full Text] [Related]
7. Subtype specificity of the muscarinic receptor-stimulated GTPase response in the rat cortex.
Ghodsi-Hovsepian S; Messer WS; Hoss W
Neurosci Lett; 1990 Mar; 110(1-2):148-54. PubMed ID: 2158014
[TBL] [Abstract][Full Text] [Related]
8. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
9. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
10. Regulation of GDP and GTP binding in cardiac sarcolemma by muscarinic receptor agonists.
Quist E
Mol Pharmacol; 1992 Jan; 41(1):168-76. PubMed ID: 1732718
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
Richardson RM; Mayanil CS; Hosey MM
Mol Pharmacol; 1991 Dec; 40(6):908-14. PubMed ID: 1758442
[TBL] [Abstract][Full Text] [Related]
13. Multiple agonist binding sites of muscarinic acetylcholine receptors and their relation to the negative inotropic action of agonists in guinea-pig heart.
Mizushima A; Uchida S; Matsumoto K; Osugi T; Kagiya T; Zhou XM; Higuchi H; Yoshida H
Eur J Pharmacol; 1985 Dec; 119(3):177-82. PubMed ID: 4092730
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
15. Partial agonist activity of oxotremorine at muscarinic acetylcholine receptors in the embryonic chick heart.
Nathanson NM; Holttum J; Hunter DD; Halvorsen SW
J Pharmacol Exp Ther; 1984 May; 229(2):455-8. PubMed ID: 6716268
[TBL] [Abstract][Full Text] [Related]
16. Decrement of muscarinic receptor-stimulated low-KM GTPase in striatum and hippocampus from the aged rat.
Yamagami K; Joseph JA; Roth GS
Brain Res; 1992 Apr; 576(2):327-31. PubMed ID: 1515926
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence for distinct muscarinic receptor subtypes coupled to the inhibition of adenylate cyclase and to the increased generation of inositol phosphates in the guinea pig myometrium.
Leiber D; Marc S; Harbon S
J Pharmacol Exp Ther; 1990 Feb; 252(2):800-9. PubMed ID: 2156062
[TBL] [Abstract][Full Text] [Related]
18. In vivo regulation of muscarinic cholinergic receptors in embryonic chick brain.
Meyer MR; Gainer MW; Nathanson NM
Mol Pharmacol; 1982 Mar; 21(2):280-6. PubMed ID: 7099136
[TBL] [Abstract][Full Text] [Related]
19. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
Graeser D; Neubig RR
Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
[TBL] [Abstract][Full Text] [Related]
20. Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors.
Daeffler L; Schmidlin F; Gies JP; Landry Y
Br J Pharmacol; 1999 Mar; 126(5):1246-52. PubMed ID: 10205015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
